Tokyo, Japan

Mitsukane Yoshinaga

This inventor holds 2 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignee: Taisho Pharmaceutical Co., Ltd.. Active years: 2015-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mitsukane Yoshinaga. Retrieved from https://idiyas.com/inventor/mitsukane-yoshinaga

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

 

 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Toshima-ku, JP (2015)
  • Tokyo, JP (2016)

Company Filing History:


Years Active: 2015-2016

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mitsukane Yoshinaga: Innovator in Pharmaceutical Development

Introduction

Mitsukane Yoshinaga is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing treatments for various mental and physical health disorders. With a total of 2 patents to his name, Yoshinaga's work is recognized for its potential impact on healthcare.

Latest Patents

Yoshinaga's latest patents focus on azole derivatives and 1,2,4-triazolone derivatives. The first patent provides agents for treating or preventing diseases such as mood disorders, anxiety disorders, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington's chorea, eating disorders, hypertension, gastrointestinal diseases, drug addiction, epilepsy, cerebral infarction, cerebral ischemia, cerebral edema, head injury, inflammation, immune-related diseases, and alopecia. Specifically, this invention offers azole derivatives represented by a general formula that exhibit antagonistic action against the arginine-vasopressin (AVP) V1b receptor. The second patent presents a 1,2,4-triazolone derivative that also targets the arginine-vasopressin 1b receptor, providing a pharmaceutical composition that serves as a therapeutic or preventive agent for similar diseases.

Career Highlights

Yoshinaga is currently employed at Taisho Pharmaceutical Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to developing effective treatments that address complex health issues.

Collaborations

Yoshinaga collaborates with notable colleagues, including Takeshi Kuwada and Naoki Miyakoshi. Their combined expertise contributes to the advancement of pharmaceutical research and development.

Conclusion

Mitsukane Yoshinaga's contributions to pharmaceutical innovations highlight his dedication to improving health outcomes through targeted treatments. His patents reflect a deep understanding of complex medical conditions and a commitment to advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…